22nd Century Group, Inc. is a biotechnology company, which engages in the business of tobacco harm reduction, reduced nicotine tobacco, and improvement of health and wellness through plant science. The company is headquartered in Williamsville, New York and currently employs 32 full-time employees. The company went IPO on 2006-10-17. The firm manufactures and distributes combustible tobacco products containing minimally or non-addictive levels of nicotine. Additionally, the Company provides turnkey contract manufacturing of cigarettes and filtered cigars for other established tobacco brands. The firm's product, VLN cigarette has 95% less nicotine than the traditional cigarette. The firm operates through a single segment named Tobacco. The company is engaged in contract manufacturing organization (CMO) customer contracts that consist of obligations to manufacture the customers' branded filtered cigars and cigarettes. The company is also engaged in the sale of its proprietary low nicotine content cigarettes, sold under the brand name VLN, or research cigarettes sold under the brand name SPECTRUM.
最新の財務諸表(Form-10K)によると、22nd Century Group Incの総資産は$0で、純損失は$0です。
XXIIの主要な財務比率は何ですか?
22nd Century Group Incの流動比率は0、純利益率は0、1株当たり売上高は$0です。
22nd Century Group Incの収益はセグメントまたは地域別にどのように分けられていますか?
22nd Century Group Inc の最大収益セグメントは Tobacco Products で、最新の利益発表における収益は 32,204,000 です。地域別に見ると、United States が 22nd Century Group Inc の主要市場であり、収益は 32,204,000 です。